Screener
Dyne Therapeutics, Inc. DYN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$120.85M-4.8% | -$111.96M-25.0% | -$108.04M-11.2% | -$110.86M-70.3% | -$115.36M-75.7% | ||
| $550K+9.6% | $521K+15.8% | $500K+25.0% | $500K+25.0% | $502K+30.1% | ||
| $13.08M+0.5% | $11.23M+7.1% | $11.08M+26.7% | $10.52M+56.2% | $13.02M-34.6% | ||
| -$144.92M-36.9% | -$111.83M-32.6% | -$90.78M-21.6% | -$94.7M-72.6% | -$105.89M-34.8% | ||
| $221K-77.5% | $484K-55.0% | $395K+56.1% | $60K-93.0% | $981K+414% | ||
| -$2.39M-264% | $0+100% | -$37.97M-95.7% | $6.77M— | $1.46M+101% | ||
| —— | $49.45M— | —— | —— | —— | ||
| $7.06M-95.0% | $430.97M+11,753% | $217.33M+1,107% | $100.77M-73.5% | $141.24M-65.4% | ||
| -$140.25M-481% | $320.12M— | $88.58M— | $12.85M-96.2% | $36.81M-75.5% | ||
| -$145.14M-35.8% | -$112.32M-31.5% | -$91.17M-21.8% | -$94.76M-70.1% | -$106.87M-35.8% |
FAQ
- How much cash does Dyne Therapeutics, Inc. generate?
- Dyne Therapeutics, Inc. (DYN) generated -$442.2M in operating cash flow over the trailing twelve months.
- What is Dyne Therapeutics, Inc.'s free cash flow?
- After $1.2M of capital expenditures, Dyne Therapeutics, Inc.'s free cash flow was -$443.4M over the trailing twelve months, down 37.3% year over year.
- Where does Dyne Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Dyne Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.